학술논문

The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up
Document Type
Academic Journal
Source
Infection and Drug Resistance. September 30, 2023, Vol. 16, p6167, 8 p.
Subject
Taiwan
Language
English
ISSN
1178-6973
Abstract
Background: Endoscopic Retrograde Cholangiopancreatography (ERCP), used for choledocholithiasis treatment, carries a risk of pyogenic liver abscess (PLA) due to communication between the biliary system and bowel contents. However, limited data exists on this issue. This study aims to identify the risk factors pertaining to liver abscesses following ERCP lithotomy. Methods: We conducted a retrospective case series across multiple centers to evaluate patients who developed PLA after ERCP for choledocholithiasis. Data was obtained from the Chung Gung Research Database (January 2001 to December 2018). Out of 220 enrolled patients, 195 were categorized in the endoscopic sphincterotomy (ES) group, while 25 were in the non-ES group for further analysis. Results: The non-ES group had significantly higher total bilirubin levels compared to the ES group (4.3 [+ or -] 5.8 vs 1.9 [+ or -] 2.0, p Conclusion: PLA incidence was higher in the ES group compared to the non-ES group following ERCP for choledocholithiasis. Attention should be given to significant risk factors, including concurrent malignancies, elevated total bilirubin levels, multiple abscess lesions, and growth of enterococcus pathogens, to reduce in-hospital mortality. Keywords: endoscopic retrograde cholangiopancreatography, pyogenic liver abscess, risk factors
Introduction The standard management for bile duct stones involves the use of ERCP with ES as the widely accepted procedure. (1,2) Despite its overall safety profile, ERCP with ES is [...]